The report announcement service for the Global Corporate Responsibility (CR) Community

ReportAlert Announcement

Latest reports > Merck (NYSE:MRK) Publishes 2012 Global Corporate Responsibility Report

Merck & Co Inc

Merck (NYSE:MRK) Publishes 2012 Global Corporate Responsibility Report

31st July, 2013

Merck, known as MSD outside of the United States and Canada, has released its 2012 Global Corporate Responsibility Report. The report, available at, focuses on Merck's corporate responsibility activities, progress and performance during 2012 in four priority areas where the company is positioned to have a positive impact: Access to Health, Environmental Sustainability, Employees, and Ethics and Transparency.

Highlights from the 2012 report include:
  • Expanding their product portfolio, as well as local development and distribution capacity, through important joint ventures
  • Developing new partnerships to reduce maternal mortality through Merck for Mothers
  • Celebrating 25 years of scientific discovery, visionary leadership and extraordinary commitment to advance the control of river blindness, or onchocerciasis, in sub-Saharan Africa, Latin America and Yemen
  • Improving wastewater quality – specifically, chemical oxygen demand (COD) – by 57 percent, and nitrogen and phosphorus by 13 percent since 2009
  • Achieving a 20 percent reduction in employee lost time injury rate
In addition, this year’s report provides information on Merck’s commitment to corporate responsibility within their Consumer Care and Animal Health businesses.

Merck uses several external guidelines and measurement frameworks to inform the scope of its reporting, including the Global Reporting Initiative (GRI 3.1) Guidelines, the Millennium Development Goals, the Access to Medicine Index and the U.N. Global Compact.

Merck welcomes your feedback at

About Merck
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit and connect with us on Twitter, Facebook and YouTube.

Forward-Looking Statement:

Share the report